RESULTS: We identified a total of 75,522 patients treated for male urethral stricture disease with 125,498 total procedures. This is the largest reported cohort of urethral stricture procedures in the literature. The majority of patients were treated with endoscopic surgery (98.8%), with only 1,515 patients undergoing urethroplasty. After adjustment, younger age (adjusted odds ratio (aOR), age 40 vs. age 60 years, 8.2; 95% CI, 7.2-9.4) and higher annual income (aOR, income $40K vs. $100,00K, 0.7; 95% CI, 0.5-0.9) were each associated with receipt of urethroplasty. Total standardized costs for endoscopic treatment was $115,724,899 compared to $3,678,066 for urethroplasty.
INTRODUCTION AND OBJECTIVES: While urethroplasty remains safe and effective in younger populations, little data exists evaluating outcomes of urethroplasty in elderly men. We report treatment outcomes, complications, and stricture characteristics among men having urethral reconstruction who were 70 years of age.
METHODS: A retrospective review of over 1000 urethroplasty cases by a single surgeon from 2007-2014 was performed to identify elderly men 70 years undergoing urethral reconstruction. Men were stratified by age and differences were assessed including stricture characteristics, postoperative complications, and surgical outcomes. Mutivariable logistic regression models evaluated the association between age and surgical outcome. Men with a history of hypospadias were excluded. RESULTS: Among 514 men having urethroplasty for which complete data was available, 85 (17%) were 70 years. Elderly men were more likely to have a history of radiation therapy (63% vs 5%, p<0.0001) and experience treatment failure (30% vs 12%, p¼0.001) during follow up (mean 20 months). Accordingly, the 24-month stricture recurrence-free survival was 61% vs 78% (p¼0.03). In men 70, the success rates of excision and primary anastomosis (EPA), substitution urethroplasty, and urethrostomy were 75%, 67%, and 80%. While stricture length, location, and prior endoscopic treatments were similar between cohorts, elderly men were more likely to have obliterative strictures (44% vs 28%), a shorter duration between diagnosis and treatment (median 46 vs 61 months), and undergo EPA (80% vs 66%). Following surgery there was no difference in overall <90 day complications (22% vs 18%); however elderly men were more likely to have a Clavien 3 or greater complication (13% vs 5%; p¼0.005). Among treatment failures, men 70 failed earlier (8 vs 18 months; p¼0.04) and were more likely to fail on subsequent intervention (55% vs 30%; p¼0.05). On multivariable analysis, radiation (OR 2.91, 95% CI 1.36-6.24; p¼0.006) and increasing age (OR 1.03, 95%CI 1.01-1.05; p¼0.006) were independently associated with risk of treatment failure.
CONCLUSIONS: While advanced age is independently associated with urethroplasty failure, urethroplasty is a safe and effective treatment option for aging men with urethral stricture disease. METHODS: Overall, 60 patients were consecutively and prospectively enrolled and underwent 18F-FACBC-PET/CT. Inclusion criteria were: intermediate and high-risk biopsy-proven PCa according to D'Amico risk group classification; standard staging workup (including 11C-Choline-PET/CT); absence of previous or ongoing androgen deprivation therapy; eligible for PLND in course of RP. Any nodal uptake greater than surrounding background was interpreted with a visual 5-point-scale (confidence of disease): 1-2 probably negative; 4-5 probably positive; 3 equivocal. Lesions' number, site and size, SUV max and target-to-background-ratio were also recorded. PET/CT results using both tracers were compared, on a perpatient basis analysis, with histopathology from extended PLND (60 patients).
Source of Funding: none
RESULTS: Main characteristics of the population are shown in Table 1 . Overall, 1342 lymph nodes were retrieved and 32 (2%) LNMs were counted. At final pathologic results, we found 9 and 15 false positive (FP) results with FACBC and Choline, respectively; while 5 false negative (FN) results were found with both tracers. The diagnostic performance of both tracers in detecting LNMs are summarized in Table 2 : sensitivity, specificity and accuracy were 58%, 69% and 67% vs. 58%, 81% and 77% for 11C-Choline PET/CT vs. 18F-fluciclovine PET/CT, respectively. CONCLUSIONS: Conclusion: 18F-fluciclovine demonstrated suboptimal sensitivity, equal to Choline, suggesting that neither tracer is ideal for PCa nodal staging. However, our preliminary data show Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 THE JOURNAL OF UROLOGY â e1187
